BIOGEN INC. Annual Nonoperating Income (Expense) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Biogen Inc. annual/quarterly Nonoperating Income (Expense) history and growth rate from 2015 to 2023.
  • Biogen Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2022 was -$263M, a 48.1% increase year-over-year.
  • Biogen Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2022 was -$852M, a 867% decline year-over-year.
  • Biogen Inc. annual Nonoperating Income (Expense) for 2023 was -$316M, a 392% decline from 2022.
  • Biogen Inc. annual Nonoperating Income (Expense) for 2022 was $108M.
  • Biogen Inc. annual Nonoperating Income (Expense) for 2021 was -$1.1B, a 320% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$316M -$424M -392% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-14
2022 $108M +$1.2B Jan 1, 2022 Dec 31, 2022 10-K 2024-02-14
2021 -$1.1B -$1.59B -320% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-14
2020 $497M +$414M +497% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-15
2019 $83.3M +$72.3M +657% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-03
2018 $11M +$228M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-03
2017 -$217M +$1.7M +0.78% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-06
2016 -$219M -$95M -76.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-06
2015 -$124M Jan 1, 2015 Dec 31, 2015 10-K 2018-02-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.